background
date
sever
clinic
laboratori
paramet
associ
sever
report
howev
paramet
observ
consist
across
studi
aim
review
assess
clinic
laboratori
paramet
may
serv
marker
predictor
sever
critic
diseas
method
conduct
systemat
search
medlin
embas
web
scienc
cinahl
googl
scholar
databas
april
review
bibliographi
elig
studi
relev
systemat
review
medrxiv
preprint
server
includ
hospitalbas
observ
studi
report
clinic
laboratori
paramet
confirm
case
exclud
studi
larg
proport
children
pregnant
women
two
author
independ
carri
screen
articl
data
extract
qualiti
assess
metaanalys
done
use
random
effect
model
metamedian
differ
mmd
confid
interv
ci
calcul
laboratori
paramet
result
fortyf
studi
countri
includ
compar
nonsever
case
sever
critic
diseas
characteris
higher
neutrophil
count
mmd
ci
cellsl
lower
lymphocyt
count
mmd
ci
cellsl
respect
notabl
result
observ
creactiv
protein
mmd
ci
mgl
mmd
ci
pgml
troponin
mmd
ngml
ddimer
mmd
mgml
respiratori
syndrom
coronaviru
phylogenet
suffici
differ
zoonot
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
introduc
human
past
two
decad
diseas
result
infect
first
report
wuhan
china
decemb
viru
rapidli
spread
region
world
thereaft
given
scale
outbreak
declar
pandem
march
world
health
organ
april
confirm
case
countriesregion
covidrel
death
clinic
featur
infect
vari
wide
classifi
mild
sever
critic
person
remain
asymptomat
major
infect
person
display
mild
symptom
similar
viral
upper
respiratori
tract
infect
dri
cough
fever
sore
throat
nasal
congest
muscl
pain
sever
characteris
featur
sever
pneumonia
dyspnoea
respiratori
frequenc
breath
per
minut
blood
oxygen
satur
critic
characteris
respiratori
failur
septic
shock
andor
multipl
organ
failur
sever
critic
highli
associ
mortal
singlecentr
observ
studi
critic
patient
critic
patient
critic
patient
requir
mechan
ventil
die
within
day
admiss
intens
care
unit
current
approv
cure
infect
effect
vaccin
yet
avail
approxim
diagnos
case
sever
critic
diseas
diagnos
requir
intens
care
manag
without
mechan
ventil
consequ
substanti
pressur
healthcar
system
worldwid
particularli
intens
care
unit
healthcar
system
becom
stretch
increas
number
case
identifi
clinic
laboratori
paramet
associ
sever
critic
case
crucial
help
clinician
triag
patient
appropri
optim
use
limit
healthcar
resourc
furthermor
clinic
trial
launch
test
possibl
treatment
laboratori
paramet
associ
sever
aid
monitor
clinic
evolut
case
trial
drug
serv
composit
secondari
outcom
trial
date
chang
sever
clinic
laboratori
paramet
link
sever
howev
clear
chang
observ
consist
across
studi
consider
mind
object
systemat
review
metaanalysi
investig
clinic
laboratori
paramet
may
associ
sever
critic
diseas
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
regist
studi
protocol
intern
prospect
regist
systemat
review
prospero
registr
number
review
metaanalysi
conduct
report
accord
prefer
report
item
systemat
review
metaanalys
prisma
statement
metaanalysi
observ
studi
epidemiolog
moos
guidelin
review
metaanalysi
includ
observ
studi
report
clinic
laboratori
paramet
among
patient
confirm
case
diagnos
use
guidelin
either
world
health
organ
china
nation
commiss
health
exposur
interest
review
sever
critic
compar
nonsever
accord
criteria
defin
china
nation
health
commiss
sever
characteris
dyspnoea
breathsminut
blood
oxygen
satur
arteri
partial
pressur
oxygen
fraction
inspir
oxygen
ratio
andor
lung
infiltr
within
hour
critic
characteris
respiratori
failur
septic
shock
andor
multipl
organ
failur
nonsever
defin
mild
pneumonia
also
consid
case
requir
oxygen
therapi
case
admit
intens
care
unit
sever
critic
case
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
includ
hospitalbas
studi
exclud
review
opinion
articl
studi
report
clinic
laboratori
paramet
stratifi
diseas
sever
also
children
pregnant
women
differ
cutoff
valu
clinic
laboratori
paramet
compar
gener
adult
exclud
studi
examin
popul
larg
proport
children
year
age
pregnant
women
reduc
clinic
heterogen
consid
studi
includ
children
pregnant
women
along
gener
adult
popul
elig
proport
children
pregnant
women
constitut
less
conduct
systemat
search
ovid
medlin
ovid
embas
clariv
analyt
web
scienc
core
collect
ebsco
cinahl
googl
scholar
databas
april
search
strategi
use
control
vocabulari
free
text
word
relev
clinic
laboratori
paramet
see
search
strategi
supplement
also
review
bibliographi
elig
studi
relev
systemat
review
identifi
addit
paper
miss
electron
search
perform
manual
search
medrxiv
preprint
server
identifi
latest
relev
studi
might
still
undergo
peerreview
search
limit
year
limit
regard
languag
public
follow
dedupl
record
retriev
systemat
search
export
retain
articl
covid
review
manag
facilit
screen
titl
abstract
follow
full
text
review
determin
elig
two
author
jm
pp
independ
carri
titl
abstract
screen
full
text
evalu
articl
use
elig
criteria
list
previou
section
discrep
studi
select
resolv
adjud
third
author
km
avoid
includ
data
patient
popul
metaanalysi
match
studi
base
locat
studi
hospit
town
period
data
collect
two
studi
conduct
locat
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
overlap
period
includ
largest
studi
unless
one
smaller
studi
present
relev
inform
includ
larger
studi
two
author
jm
pp
independ
extract
verifi
summar
data
studi
includ
metaanalysi
laboratori
paramet
report
continu
scale
number
percentag
case
cutoff
valu
report
categor
scale
discrep
collect
data
resolv
recheck
primari
studi
consensu
reach
studi
unclear
sever
classif
author
contact
seek
addit
clarif
studi
chines
languag
translat
english
languag
chines
nativ
speaker
extract
data
export
r
program
softwar
two
author
ak
mn
independ
carri
qualiti
assess
articl
use
nation
institut
health
nih
studi
qualiti
assess
tool
observ
cohort
crosssect
studi
case
seri
studi
tool
use
evalu
risk
bia
assess
overal
valid
report
result
studi
assess
use
element
relev
tool
overal
judgement
made
consid
respons
variou
element
overal
rate
poor
qualiti
translat
high
risk
bia
overal
rate
good
qualiti
translat
low
risk
bia
final
decis
studi
made
profession
judgement
consensu
among
author
evalu
impact
studi
high
risk
bia
sensit
analysi
use
leaveoneout
method
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
clinic
laboratori
paramet
measur
continu
scale
pool
median
differ
studi
use
quantil
estim
method
result
analysi
express
metamedian
differ
mmd
accompani
correspond
confid
interv
ci
prefer
median
differ
mean
differ
clinic
laboratori
indic
usual
skew
mean
valu
could
influenc
outlier
valu
particularli
small
sampl
perform
sensit
analysi
pool
mean
differ
studi
use
invers
varianc
weight
studi
report
median
iqr
total
rang
valu
comput
mean
sd
use
method
previous
describ
clinic
laboratori
paramet
measur
categor
scale
comput
preval
ratio
studi
use
count
event
exposur
compar
group
calcul
metapreval
ratio
mpr
ci
use
mantelhaenszel
method
metaanalysi
conduct
use
random
effect
model
assess
clinic
heterogen
age
distribut
comorbid
criteria
sever
studi
methodolog
heterogen
time
blood
sampl
collect
consid
potenti
impact
factor
metaanalysi
result
assess
statist
heterogen
use
cochran
q
test
calcul
statist
interpret
use
cutoff
low
moder
substanti
heterogen
respect
perform
influenc
analysi
use
leaveoneoutmethod
identifi
studi
high
influenc
result
addit
sensit
analys
perform
exclud
outlier
studi
studyspecif
estim
consid
outlier
confid
interv
overlap
confid
interv
metaestim
detect
possibl
public
bia
funnel
plot
construct
laboratori
paramet
highest
number
individu
studi
egger
test
carri
assess
statist
symmetri
plot
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
statist
analys
done
use
r
program
softwar
meta
metafor
dmetar
metadian
packag
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
identifi
studi
databas
search
sourc
figur
remov
duplic
uniqu
record
screen
remov
titl
abstract
review
addit
record
exclud
due
lack
sever
classif
lack
laboratori
paramet
record
inelig
studi
design
remain
studi
anoth
exclud
use
data
locat
cover
overlap
period
see
supplement
total
studi
retain
metaanalys
characterist
includ
studi
detail
tabl
median
mean
age
patient
includ
studi
rang
year
year
proport
male
patient
rang
patient
includ
studi
vari
proport
comorbid
hypertens
diabet
cancer
detail
tabl
forest
plot
leaveoneout
analysi
display
supplement
pertain
haematolog
paramet
major
studi
report
higher
white
cell
count
higher
neutrophil
count
sever
critic
patient
rel
nonsever
threat
valid
metaanalysi
fall
two
broad
categori
risk
bia
individu
studi
public
bia
across
bodi
literatur
assess
two
categori
threat
valid
present
use
nih
studi
qualiti
assess
tool
studi
rate
low
risk
bia
studi
rate
medium
risk
bia
studi
rate
high
risk
bia
major
studi
clearli
defin
studi
object
welldefin
studi
popul
compar
subject
contrast
studi
provid
sampl
size
calcul
power
descript
studi
rate
high
risk
bia
element
assess
tempor
sequenc
laboratori
measur
diseas
sever
none
report
result
adjust
potenti
confound
figur
supplement
result
markedli
differ
sensit
analys
exclud
studi
high
risk
bia
symmetri
funnel
plot
obtain
laboratori
paramet
highest
number
individu
studi
assess
use
egger
test
symmetr
funnel
plot
creactiv
protein
p
creatinin
p
suggest
evid
public
bia
wherea
asymmetr
funnel
plot
white
cell
count
p
lymphocyt
count
p
indic
signific
influenc
smaller
studi
may
indic
public
bia
figur
import
note
egger
test
may
robust
creactiv
protein
white
cell
count
lymphocyt
paramet
due
substanti
heterogen
sensit
analys
exclud
outlier
studi
statist
heterogen
reduc
metaestim
laboratori
paramet
markedli
alter
sensit
analysi
use
mean
differ
supplement
substanti
heterogen
laboratori
paramet
associ
observ
use
median
differ
persist
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
discuss
rapidli
evolv
pandem
signific
global
morbid
mortal
aim
metaanalysi
investig
clinic
laboratori
paramet
may
associ
sever
critic
diseas
clinic
laboratori
paramet
evalu
found
derang
clinic
laboratori
paramet
significantli
associ
sever
critic
whilst
observ
associ
may
clinic
relev
certain
pronounc
laboratori
abnorm
may
import
clinic
implic
marker
overact
innat
immun
system
markedli
elev
neutrophiltolymphocyt
ratio
nlr
serum
ferritin
creactiv
protein
marker
defici
adapt
immun
system
lymphocyt
count
could
help
recognis
potenti
sever
infect
triag
marker
organ
failur
could
help
monitor
evolut
hospitalis
patient
follow
infect
viru
innat
immun
system
activ
earli
respons
nonspecif
serv
limit
viru
multipl
acut
phase
adapt
immun
system
activ
day
later
respons
specif
respons
immunomodulatori
via
engag
helper
cell
regulatori
cell
produc
immunolog
memori
elev
lymphocyt
count
commonli
found
viral
infect
magnitud
qualiti
cell
respons
may
determin
fate
infect
failur
mount
appropri
adapt
immun
respons
mean
innat
immun
respons
remain
continu
stimul
deleteri
effect
lung
organ
found
sever
critic
patient
increas
marker
innat
immun
system
activ
compar
patient
nonsever
diseas
evidenc
significantli
higher
level
neutrophil
acut
phase
reaction
marker
crp
esr
serum
ferritin
well
decreas
concentr
albumin
prealbumin
sever
critic
patient
also
exhibit
defect
adapt
immun
respons
evidenc
significantli
lower
level
lymphocyt
subset
count
current
use
defin
sever
case
hiv
infect
case
hiv
viru
directli
infect
cell
use
envelop
glycoprotein
variou
author
suggest
could
deplet
lymphocyt
directli
infect
lymphocyt
indirectli
lymphocyt
apoptosi
induc
persist
elev
inflammatori
cytokin
sinc
sever
patient
display
reduc
lymphocyt
count
like
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
patient
diseas
sever
known
addit
mani
studi
china
report
overlap
patient
popul
tri
exclud
studi
reli
data
possibl
associ
examin
metaanalysi
base
nonindepend
observ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
author
contribut
jm
pp
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
